These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Sekut L; Yarnall D; Stimpson SA; Noel LS; Bateman-Fite R; Clark RL; Brackeen MF; Menius JA; Connolly KM Clin Exp Immunol; 1995 Apr; 100(1):126-32. PubMed ID: 7697910 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. Bissonnette EY; Befus AD J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):825-31. PubMed ID: 9438493 [TBL] [Abstract][Full Text] [Related]
4. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers. Yang Q; Battistini B; Pelletier S; Sirois P Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004 [TBL] [Abstract][Full Text] [Related]
6. Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation. Oddera S; Silvestri M; Testi R; Rossi GA Respiration; 1998; 65(3):199-204. PubMed ID: 9670302 [TBL] [Abstract][Full Text] [Related]
7. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms. Chong LK; Cooper E; Vardey CJ; Peachell PT Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032 [TBL] [Abstract][Full Text] [Related]
8. Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists. Goleva E; Dunlap A; Leung DY J Allergy Clin Immunol; 2004 Jul; 114(1):183-91. PubMed ID: 15241363 [TBL] [Abstract][Full Text] [Related]
9. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Donnelly LE; Tudhope SJ; Fenwick PS; Barnes PJ Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732 [TBL] [Abstract][Full Text] [Related]
10. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Seldon PM; Barnes PJ; Meja K; Giembycz MA Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the profiles of agonists as stimulants of the beta 3-adrenoceptor in vitro with their gastroprotective effects in the conscious rat. Bahl AK; Clayton NM; Coates J; Martin DP; Oakley IG; Strong P; Trevethick MA Br J Pharmacol; 1996 Feb; 117(3):580-586. PubMed ID: 8821552 [TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Pang L; Knox AJ Am J Respir Cell Mol Biol; 2000 Jul; 23(1):79-85. PubMed ID: 10873156 [TBL] [Abstract][Full Text] [Related]
13. Effects of salmeterol on muscarinic inhibition of adenylyl cyclase in bovine trachealis cells. Ethier MF; Dextradeur T; Schaefer OP; Madison JM Life Sci; 2000 Oct; 67(22):2753-8. PubMed ID: 11105991 [TBL] [Abstract][Full Text] [Related]
14. Salmeterol inhibits interferon-gamma and interleukin-4 production by human peripheral blood mononuclear cells. Mohede IC; Van Ark I; Brons FM; Van Oosterhout AJ; Nijkamp FP Int J Immunopharmacol; 1996 Mar; 18(3):193-201. PubMed ID: 8796447 [TBL] [Abstract][Full Text] [Related]
15. Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line. McCrea KE; Hill SJ Br J Pharmacol; 1993 Oct; 110(2):619-26. PubMed ID: 7902176 [TBL] [Abstract][Full Text] [Related]
16. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Whelan CJ; Johnson M Br J Pharmacol; 1992 Apr; 105(4):831-8. PubMed ID: 1354536 [TBL] [Abstract][Full Text] [Related]
17. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. Pang L; Knox AJ FASEB J; 2001 Jan; 15(1):261-269. PubMed ID: 11149914 [TBL] [Abstract][Full Text] [Related]
18. Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha). Finney PA; Donnelly LE; Belvisi MG; Chuang TT; Birrell M; Harris A; Mak JC; Scorer C; Barnes PJ; Adcock IM; Giembycz MA Br J Pharmacol; 2001 Mar; 132(6):1261-70. PubMed ID: 11250877 [TBL] [Abstract][Full Text] [Related]
19. Salmeterol attenuates the inflammatory response in asthma and decreases the pro-inflammatory cytokine secretion of dendritic cells. Hu Z; Chen R; Cai Z; Yu L; Fei Y; Weng L; Wang J; Ge X; Zhu T; Wang J; Bai C Cell Mol Immunol; 2012 May; 9(3):267-75. PubMed ID: 22231554 [TBL] [Abstract][Full Text] [Related]
20. Salmeterol, a Long-Acting β2-Adrenergic Receptor Agonist, Inhibits Macrophage Activation by Lipopolysaccharide From Porphyromonas gingivalis. Sharma M; Patterson L; Chapman E; Flood PM J Periodontol; 2017 Jul; 88(7):681-692. PubMed ID: 28398147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]